uniformity. In fact, if you go back and recall, one of the slides Tom Layloff presented in his presentation on content uniformity for tablets, it's a direct link to that. I'm very excited about this proposal. Conceptually, I think we are in agreement that this is the direction we would like to go, and why are we so excited about this proposal?
In Tom Layloff's presentation, you saw our current approach to many of the tests that we have, say, in the USP content uniformity are zero tolerance tests. USP tests were essentially evolved as a market standard where a pharmacist or physician can take 10, 20, 30 tablets and say yes, no doubt it is outside 75 to 125.
The parametric approach that you will hear today, I think, is an evolutionary step in sort of bringing the current state of statistical science to bear on certain decisions, and you actually take into consideration the variability, the underlying distributions, and actually you can make better decisions with this.
That is so critical as we move towards the future. The reason is, if you have now the capability,